↓ Skip to main content

Dove Medical Press

MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit

Overview of attention for article published in Drug Design, Development and Therapy, July 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
13 Mendeley
Title
MicroRNA-664 suppresses the growth of cervical cancer cells via targeting c-Kit
Published in
Drug Design, Development and Therapy, July 2019
DOI 10.2147/dddt.s203399
Pubmed ID
Authors

Mingfen Lv, Rongying Ou, Qianwen Zhang, Fan Lin, Xiangyun Li, Keyu Wang, Yunsheng Xu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 1 8%
Student > Bachelor 1 8%
Professor 1 8%
Student > Ph. D. Student 1 8%
Student > Master 1 8%
Other 1 8%
Unknown 7 54%
Readers by discipline Count As %
Medicine and Dentistry 4 31%
Biochemistry, Genetics and Molecular Biology 2 15%
Unknown 7 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2019.
All research outputs
#17,579,816
of 25,774,185 outputs
Outputs from Drug Design, Development and Therapy
#1,129
of 2,281 outputs
Outputs of similar age
#232,403
of 365,015 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 41 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,281 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,015 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.